Merrell Woodson C, Shalts Edward
Continuum Center for Health and Healing, Beth Israel Medical Center, New York, New York, USA.
Med Clin North Am. 2002 Jan;86(1):47-62. doi: 10.1016/s0025-7125(03)00071-3.
Especially in the United States, homeopathy has not become integrated into mainstream medical practice; this is partly because of the historical paucity of quality published research studies or quality educational programs. More recently, there have been better-designed studies in reputable journals, although historically most studies have been inconclusive or of poor methodology. The confusion around homeopathy in the United States exists for several reasons: 1. One of the main reasons for the relative disinterest or opposition to homeopathy is that even well-designed clinical studies on homeopathy leave the reader without any protocol-driven tools to take into daily practice. Individualization of treatment, or, as it is called today, differential therapeutics, is the main requirement of successful homeopathic prescribing. Only well-trained homeopathic practitioners are able to carry out such a task. In many articles that reported positive outcomes for homeopathy, numerous homeopathic remedies had been prescribed for the same diagnostic category. Critics suggest that the pooling of data from trials using different therapeutic agents to assess the overall success of homeopathic prescribing is incorrect. Research protocols that employ combination remedies, in which a medication contains several homeopathic remedies, fall into the same category. 2. Many of the positive and negative studies published are flawed with numerous methodologic problems. One of the most common problems is a lack of objective validated outcome measures. Another common problem is a small sample size. In most positive and negative meta-analyses published to date, research data are pulled together artificially based on either a diagnostic category or a particular remedy. Frequently the concentration of the remedy used and the conditions to which it has been applied are different. Ernst and Pittler published a letter with a critique of the methodology used in one of the meta-analyses of clinical trials of homeopathy. Most importantly, professional homeopaths and conventional scientists criticize the choice of remedy or the condition to which it was applied or both. The design and follow-up in migraine studies has been criticized extensively by one of the world's leading homeopaths, Vithoulkas (personal communication, 1997). Most of the Arnica studies have been designed with either an inappropriate dosing regimen or an inappropriately chosen procedure. In most positive studies on homeopathy, the outcome measures were subjective and poorly quantifiable. 3. Few well-designed studies have been reproduced by independent research teams. This situation exists for two major reasons: lack of sufficient funding and lack of a sufficient number of well-trained homeopaths qualified and interested to participate in research. 4. More rigorous educational programs on homeopathy for professionals need to be encouraged. Most of the existing programs are designed for consumers; academic continuing medical education-quality courses are needed. Meanwhile, while the debate around homeopathy still continues in conventional medical circles, the general public has been using the services of homeopathic practitioners and homeopathic remedies increasingly. In many countries, homeopathy and other complementary modalities have been integrated successfully into a larger armamentarium for the modern physician. According to a study published in 1995 in the Journal of the American Board of Family Practice, 69% of family practice physicians expressed interest in learning more about homeopathy. Increasing public and professional interest calls for attempts to study homeopathy in a more systematic way and to provide quality academic overview for medical practitioners. The growing number of complementary and alternative medicine centers affiliated with major teaching hospitals should provide a solid interface between evidence-based biologic medicine and many emerging complementary and alternative medicine modalities, including homeopathy.
尤其在美国,顺势疗法尚未融入主流医疗实践;部分原因在于过去高质量的已发表研究及高质量教育项目较为匮乏。近年来,知名期刊上出现了设计更精良的研究,不过从历史来看,多数研究结果尚无定论或方法欠佳。美国围绕顺势疗法存在困惑有以下几个原因:1. 对顺势疗法相对不感兴趣或持反对态度的主要原因之一是,即便设计精良的顺势疗法临床研究也未给读者留下可应用于日常实践的、基于方案的工具。个性化治疗,即如今所说的差异疗法,是成功进行顺势疗法开方的主要要求。只有训练有素的顺势疗法从业者才能完成此项任务。在许多报告顺势疗法有积极效果的文章中,针对同一诊断类别开出了众多顺势疗法药物。批评者指出,将使用不同治疗药物的试验数据汇总以评估顺势疗法开方的总体成功率是不正确的。采用复方药物(一种药物包含多种顺势疗法药物)的研究方案也属于此类情况。2. 已发表的许多关于顺势疗法的正面和负面研究都存在诸多方法学问题。最常见的问题之一是缺乏客观有效的结果衡量标准。另一个常见问题是样本量小。在迄今为止发表的多数正面和负面荟萃分析中,研究数据是基于诊断类别或特定药物人为汇总的。所用药物的浓度及其应用条件常常不同。恩斯特和皮特勒发表了一封信,批评了顺势疗法临床试验的一项荟萃分析中所使用的方法。最重要的是,专业顺势疗法从业者和传统科学家批评药物的选择、其应用的病症或两者皆有问题。世界顶尖顺势疗法从业者之一维图尔卡斯(个人交流,1997年)广泛批评了偏头痛研究的设计和随访情况。多数山金车属植物研究的设计要么给药方案不当,要么程序选择不当。在多数关于顺势疗法的正面研究中,结果衡量标准主观且难以量化。3. 很少有设计精良的研究被独立研究团队重复验证。出现这种情况主要有两个原因:缺乏足够资金以及缺乏足够数量训练有素、有资质且有兴趣参与研究的顺势疗法从业者。4. 需要鼓励为专业人员提供更严格的顺势疗法教育项目。现有的多数项目是为消费者设计的;需要学术性的继续医学教育质量课程。与此同时,虽然传统医学界围绕顺势疗法的争论仍在继续,但公众越来越多地使用顺势疗法从业者的服务和顺势疗法药物。在许多国家,顺势疗法和其他补充疗法已成功融入现代医生的更大武器库。根据1995年发表在《美国家庭医疗委员会杂志》上的一项研究,69%的家庭医疗医生表示有兴趣更多地了解顺势疗法。公众和专业人士兴趣日增,这就要求尝试以更系统的方式研究顺势疗法,并为医学从业者提供高质量的学术综述。与主要教学医院相关联的补充和替代医学中心数量不断增加,应在循证生物医学与许多新兴的补充和替代医学模式(包括顺势疗法)之间提供坚实的衔接。